CASEY WHITE: Open Payments
NPI 1740906437 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 39 payments from 6 companies in 2025. Trend: 2023 $210 · 2024 $557 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $250 |
| Madrigal Pharmaceuticals | 7 | $226 |
| Intercept Pharmaceuticals, Inc. | 7 | $210 |
| Ipsen Biopharmaceuticals, Inc | 6 | $105 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Eton Pharmaceuticals, Inc. | 1 | $24 |
Products named: REZDIFFRA, OCALIVA, IQIRVO, XIFAXAN, ALKINDI.
Industry payments across OK — which companies pay providers there.
